Protocol for the Examination of Radical Prostatectomy ...
Transurethral resection of the prostate (TURP) and enucleation specimens (simple or subtotal prostatectomy) (consider Prostate TURP protocol) Biopsy (consider the Prostate Biopsy protocol) Primary resection specimen with no residual cancer (eg, following neoadjuvant therapy) Cytologic specimens
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Risk Management Guide - College of American Pathologists
documents.cap.org• ISO 31000:2009, Risk management—Principles and guidelines • CLSI EP23-A, Laboratory Quality Control Based on Risk Management; Approved Guideline References 1. ISO 14971:2007, Medical devices—Application of risk management to medical devices; specifically Annex H, Guidance on risk management for in vitro diagnostic medical devices 2.
CAP Accreditation Checklists 2021 Edition
documents.cap.orgImmunology • General immunology assays, manual and automated • Immune system profiles • Tumor marker and infectious disease immunoassays • Microbial antigen testing • Waived molecular-based microbiology tests • ABO/Rh and antibody screening (non-transfusion related) • Syphilis serology • HIV Primary diagnostic testing
PROFICIENCY TESTING MANUAL
documents.cap.orgProficiency Testing Manual College of American Pathologists 5 General Customer Information PT Referral Information Per CLIA, as published by the United States Federal Register, PT specimens must be tested with the laboratory’s regular …
Medicare Clinical Laboratory Fee Schedule
documents.cap.org86160 Complement antigen $16.46 $10.70 $14.81 -10% 86235 Nuclear antigen antibody $24.60 $15.87 $22.14 -10% 86300 Immunoassay tumor ca 15-3 $28.55 $18.54 $25.70 -10% 86431 Rheumatoid factor quant $7.78 $5.06 $7.00 -10% 86803 Hepatitis c ab test $19.57 $12.71 $17.61 …
CAP Personnel Requirements by Testing Complexity
documents.cap.orgJul 18, 2016 · science or medical laboratory technology; OR 6. High school graduate or equivalent and laboratory training/experience consisting of the following: a. Successfully completed military training of 50 or more weeks and served as a medical laboratory specialist; OR b. Appropriate training/experience as specified in
Laboratory, Medical, Requirements, Medical laboratory, Sciences, Complexity
Protocol for the Examination of Resection Specimens from ...
documents.cap.orgProtocol for the Examination of Resection Specimens from Patients with Invasive Carcinoma of the Breast . Version: 4.5.0.1 . Protocol Posting Date: November 2021 . CAP Laboratory Accreditation Program Protocol Required Use Date: March 2022 .
Form, Patients, Examination, Specimen, Carcinoma, Specimens from patients
Protocol for the Examination of Resection Specimens From ...
documents.cap.orgProtocol for the Examination of Resection Specimens From Patients With Invasive Carcinoma of the Breast Version: Breast Invasive Resection 4.4.0.0 Protocol Posting Date: February 2020 CAP Laboratory Accreditation Program Protocol Required Use Date: November 2020 Includes pTNM requirements from the 8th Edition, AJCC Staging Manual
Form, Patients, Examination, Specimen, Carcinoma, Specimens from patients
Colon and Rectum - College of American Pathologists
documents.cap.orgEdition, AJCC Staging Manual. For accreditation purposes, this protocol should be used for the following procedures AND tumor types: Procedure Description . Colectomy Includes specimens designated total, partial, or segmental resection Rectal Resection Includes specimens designated low anterior resection or abdominoperineal resection
Protocol for the Examination of Specimens From Patients ...
documents.cap.orgHistologic Type (Note C) ___ Adenocarcinoma Lauren Classification of Adenocarcinoma ... ___ Mucinous adenocarcinoma (greater than 50% mucinous) ___ Papillary adenocarcinoma ... If there is perforation of the visceral peritoneum covering the gastric ligaments or the omentum, the tumor should be classified as T4.
Types, Gastric, Adenocarcinoma, Mucinous, Mucinous adenocarcinoma
Practical Guide to Specimen Handling in Surgical Pathology
documents.cap.orgAll Common Checklist, COM.06100 – Primary Specimen Container Labeling All Common Checklist, COM.06200 - Pathologists Pathology and Laboratory ... • Written documentation for the correction of labelling errors – to be followed when specimens cannot be replaced ... • Bar coding and/or RFID documentation must be validated and maintained.
Related documents
Genetic Testing for Hereditary Cancer - UHCprovider.com
www.uhcprovider.comBRCA-Related Cancers: Breast cancer, Ovarian cancer, pancreatic cancer or metastatic or high-risk (Gleason score >=7) prostate cancer (National Comprehensive Cancer Network [NCCN], 2022). Breast Cancer: Either invasive carcinomas or non-invasive (in situ) ductal carcinoma types (NCCN, 2022).
2020 Medicines in Development ꟷ Cancer
www.phrma.orgAB928 (etrumadenant) Arcus Biosciences 3L colorectal cancer, 1L NSCLC, Phase II (A2A/A2B receptor antagonist) Hayward, CA pancreatic ductal adenocarcinoma www.gilead.com Gilead Sciences Foster City, CA colorectal cancer, castration-resistant Phase I prostate cancer, triple negative www.gilead.com breast cancer, NSCLC
The Cancer Research Network Presents the: 2021 ...
www.sydney.edu.auof cancer researchers, and through its activities ... #006 Profiling prostate cancer genetic risk associated with African ancestry School of Medical Sciences, Faculty of ... #010 Integrated Mapping of the Ductal Carcinoma In Situ Ecosystem to Predict Disease Outcome School of Medical Sciences, Faculty of
Molecular Oncology Testing for Cancer Diagnosis, Prognosis ...
www.uhcprovider.comGene Expression Tests for breast cancer are unproven and not medically necessary for all other indications, including ductal carcinoma in situ (DCIS), due to insufficient evidence of efficacy. • Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions Medicare Advantage Coverage Summaries • Genetic Testing
Treatment, Decision, Diagnosis, Cancer, Prognosis, Ductal, Cancer diagnosis, And treatment decisions
Providence Health Plan Combined Prior Authorization List
s3-us-west-2.amazonaws.comTesting for Breast Cancer (Medicare Only) Medicare 0047U Oncology (prostate), mRNA, gene expression profiling by real-time RT-PCR of 17 genes (12 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score 10/01/2018 Prostate: Protein Biomarkers and Genetic Testing (Medicare Only)
Lists, Authorization, Prostate, Cancer, Prior, Prior authorization list
James Patient Education Handouts A-Z
healthsystem.osumc.eduJames Patient Education Handouts (A – Z) Click on the title to see the handout To narrow your search use “Ctrl + F” and enter a keyword . The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute